Timing or criteria to trigger adaptive radiotherapy (ART) for nasopharyngeal carcinoma (NPC): A systematic review
Abstract
Introduction: Nasopharyngeal carcinoma (NPC), prevalent in Southern China and Southeast Asia, is primarily treated with radiation therapy (RT) and concurrent chemoradiotherapy (CCRT). Due to its anatomical complexity and changes during treatment, adaptive radiotherapy (ART) is employed to adjust plans mid-course. However, ART is time-consuming and labor intensive. This systematic review aims to summarize and analyze the timepoints and criteria used to trigger replanning in NPC patients undergoing ART.
Methods: A systematic search was conducted in PubMed and Scopus to identify studies reporting on the timing or criteria for replanning in NPC patients treated with ART. Eligible studies were screened, and relevant data were extracted.
Results: 51 studies met the inclusion criteria. Among these, 42 recommended a single replanning session, 3 suggested one or two sessions depending on individual factors, 4 proposed two sessions, and 2 recommended three. Week 5 was the most frequently reported timepoint for initiating ART, followed by weeks 4 and 3. Tumor volume reduction was a common criterion. Changes in parotid gland anatomy and dosimetric parameters were frequently cited due to their relevance as organs at risk. Body weight loss was a triggering factor in eleven studies, while four studies highlighted ill-fitted masks as indicators for ART initiation.
Conclusion: There is notable variability in the timing or criteria for initiating ART in NPC patients. Prospective studies are…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.